SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-08-011165
Filing Date
2008-02-21
Accepted
2008-02-21 16:53:07
Documents
3
Group Members
D. E. SHAW & CO., L.P.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 v104332_sc13g.htm SC 13G 180446
2 v104332_ex1.htm EX-1 9549
3 v104332_ex2.htm EX-2 19059
  Complete submission text file 0001144204-08-011165.txt   211045
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Subject) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-60323 | Film No.: 08633483
SIC: 2834 Pharmaceutical Preparations

Mailing Address 39TH FLOOR, TOWER 45 120 WEST FORTY-FIFTH STREET NEW YORK NY 10036
Business Address 39TH FLOOR, TOWER 45 120 WEST FORTY-FIFTH STREET NEW YORK NY 10036 (212) 478-0000
D. E. Shaw Valence Portfolios, L.L.C. (Filed by) CIK: 0001294704 (see all company filings)

IRS No.: 134046559 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G